Andreeff Sheds Light on the Evaluation of the E-selectin Antagonist Uproleselan in AML
Season 8, Episode 49, May 29, 2023, 06:00 PM
Dr Andreeff discusses the evaluation of uproleselan for the treatment of patients with acute myeloid leukemia, the rationale for targeting E-selectin in patients with this disease, how uproleselan could amplify the effects of chemotherapy in the treatment of these patients.